An Overview of Diabetes Management in Schizophrenia Patients: Office Based Strategies for Primary Care Practitioners and Endocrinologists

摘要: Diabetes is common and seen in one five patients with schizophrenia. It more prevalent than the general population contributes to increased morbidity shortened lifespan this population. However, screening treatment for diabetes other metabolic conditions remain poor these patients. Multiple factors including genetic risk, neurobiologic mechanisms, psychotropic medications, environmental contribute prevalence of diabetes. Primary care physicians should be aware adverse effects medications that can cause or exacerbate its complications. Management requires tailor recommendations address special needs In addition behavioral interventions, such as metformin have shown promise attenuating weight loss preventing hyperglycemia those being treated antipsychotic medications. Targeted prevention critical schizophrenia evidence-based interventions considered early course treatment. This paper reviews prevalence, etiology, outlines office based treating vulnerable